Anaptysbio (ANAB) Receivables: 2016-2025
Historic Receivables for Anaptysbio (ANAB) over the last 5 years, with Sep 2025 value amounting to $75.7 million.
- Anaptysbio's Receivables rose 520.62% to $75.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $155.8 million, marking a year-over-year increase of 343.21%. This contributed to the annual value of $40.8 million for FY2024, which is 495.02% up from last year.
- As of Q3 2025, Anaptysbio's Receivables stood at $75.7 million, which was up 253.37% from $21.4 million recorded in Q2 2025.
- Over the past 5 years, Anaptysbio's Receivables peaked at $75.7 million during Q3 2025, and registered a low of $642,000 during Q2 2021.
- In the last 3 years, Anaptysbio's Receivables had a median value of $9.0 million in 2024 and averaged $18.1 million.
- Its Receivables has fluctuated over the past 5 years, first tumbled by 75.06% in 2021, then soared by 520.62% in 2025.
- Quarterly analysis of 5 years shows Anaptysbio's Receivables stood at $876,000 in 2021, then surged by 61.99% to $1.4 million in 2022, then soared by 382.80% to $6.9 million in 2023, then skyrocketed by 495.02% to $40.8 million in 2024, then soared by 520.62% to $75.7 million in 2025.
- Its Receivables was $75.7 million in Q3 2025, compared to $21.4 million in Q2 2025 and $17.9 million in Q1 2025.